rTMS: repetitive transcranial magnetic stimulation
rTMS: repetitive transcranial magnetic stimulation is a medical device with 7 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 4 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 1Trial Status & Enrollment
100.0%
4 of 4 finished
0.0%
0 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of Non-Invasive Neuromodulation on Primary Chronic Pain, Including Post-COVID-19
rTMS in Children and Adolescents With ADHD:
rTMS Over the Supplementary Motor Area for Treatment-resistant Obsessive-compulsive Disorder.
Efficacity of rTMS in Alcohol Dependance
Effect of High Frequency Transcranial Magnetic Stimulation on Recovery of Chronic Post-Stroke Aphasia
Clinical Trials (7)
Effect of Non-Invasive Neuromodulation on Primary Chronic Pain, Including Post-COVID-19
rTMS in Children and Adolescents With ADHD:
rTMS Over the Supplementary Motor Area for Treatment-resistant Obsessive-compulsive Disorder.
Efficacity of rTMS in Alcohol Dependance
Effect of High Frequency Transcranial Magnetic Stimulation on Recovery of Chronic Post-Stroke Aphasia
Effects of Treatment of PTSD on Reduced Recall for Fear Extinction
Repetitive Transcranial Magnetic Stimulation
All 7 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 7